USANA Health Sciences, Inc. (NYSE:USNA) Insider David Mulham Mulham Sells 3,234 Shares

USANA Health Sciences, Inc. (NYSE:USNA) insider David Mulham Mulham sold 3,234 shares of the business’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $32.98, for a total value of $106,657.32. Following the transaction, the insider now owns 12,775 shares in the company, valued at approximately $421,319.50. This represents a 20.20 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

USANA Health Sciences Trading Down 0.2 %

Shares of USNA stock traded down $0.06 during midday trading on Tuesday, reaching $33.03. 81,747 shares of the stock were exchanged, compared to its average volume of 174,238. USANA Health Sciences, Inc. has a 1 year low of $27.71 and a 1 year high of $50.32. The firm has a market cap of $629.46 million, a PE ratio of 11.67, a price-to-earnings-growth ratio of 0.93 and a beta of 0.98. The company’s 50 day moving average is $32.96 and its two-hundred day moving average is $36.18.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.15. The company had revenue of $213.61 million for the quarter, compared to analysts’ expectations of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. As a group, equities analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of USNA. Pacer Advisors Inc. increased its stake in shares of USANA Health Sciences by 16.5% during the third quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock valued at $20,638,000 after purchasing an additional 76,904 shares in the last quarter. Pzena Investment Management LLC grew its stake in shares of USANA Health Sciences by 7.5% in the 3rd quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock worth $39,801,000 after buying an additional 72,977 shares during the last quarter. Dimensional Fund Advisors LP increased its position in USANA Health Sciences by 7.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock valued at $27,751,000 after buying an additional 55,059 shares in the last quarter. Jane Street Group LLC raised its stake in USANA Health Sciences by 330.0% during the fourth quarter. Jane Street Group LLC now owns 39,979 shares of the company’s stock valued at $1,435,000 after buying an additional 30,681 shares during the last quarter. Finally, Norges Bank bought a new stake in USANA Health Sciences in the fourth quarter worth $953,000. 54.25% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

USNA has been the topic of several research analyst reports. DA Davidson reduced their target price on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, February 27th. StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Finally, Sidoti cut shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.